Raj is a scientist by training and an entrepreneur by passion. He brings two decades of experience as a cancer researcher and a track-record of turning basic research into clinical assets.
During his doctoral studies at Institute for Experimental Cancer Research-EPFL, he established a drug discovery platform to target undruggable Transcription Factors to address diseases such as cancer, auto-immune and inflammatory disorders. Building upon that platform, Raj co-founded Cellestia Biotech.
“It is exciting to see how my basic research into mechanism of human diseases and discovery platform making a positive difference for patients suffering with diseases such as cancer. This is one of the most exhilarating and satisfying experience I ever had. This is what I get up to do every morning.”
Raj is winner of several national and international awards for excellence in science and entrepreneurship (Canadian Genetic Disease Network scholarship, the American Association for Cancer Research-Scholar in Training award, a University of Toronto fellowship, the Frank Fletcher Memorial scholarship for cancer research, the Al and Hannah Peryl Graduate student scholarship, Innogrant, Swiss National team of venture leaders in 2013 and 2018). He also mentors budding Swiss entrepreneurs in an Innosuisse sponsored program.
Currently Raj Lehal serves as Chief Scientific Officer and member of the Board of Directors at Cellestia Biotech.